[1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]-morpholin-4-ylmethanone

C16H24N4O2 — CID 163352719

IUPAC[1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]-morpholin-4-ylmethanone
SMILESCC(C)(C)c1ccc(N2CC(C(=O)N3CCOCC3)C2)nn1
InChIInChI=1S/C16H24N4O2/c1-16(2,3)13-4-5-14(18-17-13)20-10-12(11-20)15(21)19-6-8-22-9-7-19/h4-5,12H,6-11H2,1-3H3
InChIKeyGGNFLKSYGNSKRD-UHFFFAOYSA-N
MW304.39 g/mol
LogP1.07
Rot. Bonds2

About [1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]-morpholin-4-ylmethanone

[1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]-morpholin-4-ylmethanone (PubChem CID 163352719) has the molecular formula C16H24N4O2 and a molecular weight of 304.39 g/mol. Its IUPAC name is [1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]-morpholin-4-ylmethanone.

Molecular Properties

Compound Name[1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]-morpholin-4-ylmethanone
PubChem CID163352719
Molecular FormulaC16H24N4O2
Molecular Weight304.39 g/mol
Exact Mass304.19
IUPAC Name[1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]-morpholin-4-ylmethanone
SMILESCC(C)(C)c1ccc(N2CC(C(=O)N3CCOCC3)C2)nn1
InChIInChI=1S/C16H24N4O2/c1-16(2,3)13-4-5-14(18-17-13)20-10-12(11-20)15(21)19-6-8-22-9-7-19/h4-5,12H,6-11H2,1-3H3
InChIKeyGGNFLKSYGNSKRD-UHFFFAOYSA-N
XLogP1.07
TPSA58.56 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds2
Heavy Atoms22
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500304.39
LogP ≤ 51.07
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Analyze [1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]-morpholin-4-ylmethanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-2-yl-[1-(6-tert-butylpyridazin-3-yl)pyrrolidin-3-yl]methanone
CID 175648275
N-tert-butyl-1-(6-tert-butylpyridazin-3-yl)azetidine-3-carboxamide
CID 165434484
[1-(6-cyclopropylpyridazin-3-yl)pyrrolidin-3-yl]-morpholin-4-ylmethanone
CID 165434865
morpholin-4-yl-(1-quinolin-2-ylazetidin-3-yl)methanone
CID 163353117
3-tert-butyl-6-(3,5-dimethylpiperidin-1-yl)pyridazine
CID 129258348
morpholin-4-yl-(1-pyridin-4-ylazetidin-3-yl)methanone
CID 163357808
morpholin-4-yl-(1-pyrazin-2-ylazetidin-3-yl)methanone
CID 163352710
1-[2-[[[1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]-methylamino]methyl]morpholin-4-yl]ethanone
CID 126918327
1-[[1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]methyl]-3-(oxan-4-yl)urea
CID 126917727
morpholin-4-yl-(1-quinoxalin-2-ylazetidin-3-yl)methanone
CID 163353090
oxan-4-yl-[4-(6-pyrrolidin-1-ylpyridazin-3-yl)piperazin-1-yl]methanone
CID 122334392
[2-(6-tert-butylpyridazin-3-yl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrol-5-yl]-pyridin-4-ylmethanone
CID 146080091

Frequently Asked Questions

What is the IUPAC name of [1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]-morpholin-4-ylmethanone?
The IUPAC name of [1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]-morpholin-4-ylmethanone (CID 163352719) is [1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]-morpholin-4-ylmethanone.
What is the SMILES notation for [1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]-morpholin-4-ylmethanone?
The canonical SMILES for [1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]-morpholin-4-ylmethanone is CC(C)(C)c1ccc(N2CC(C(=O)N3CCOCC3)C2)nn1.
What is the InChIKey of [1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]-morpholin-4-ylmethanone?
The InChIKey is GGNFLKSYGNSKRD-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H24N4O2/c1-16(2,3)13-4-5-14(18-17-13)20-10-12(11-20)15(21)19-6-8-22-9-7-19/h4-5,12H,6-11H2,1-3H3.
What are the key properties of [1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]-morpholin-4-ylmethanone?
[1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]-morpholin-4-ylmethanone has a molecular weight of 304.39 g/mol, XLogP of 1.07, 2 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [1-(6-tert-butylpyridazin-3-yl)azetidin-3-yl]-morpholin-4-ylmethanone is sourced from PubChem (CID 163352719), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).